IntrinsicIntrinsic
← Scroll for more →

Financial Statements — BHVN

Balance Sheet

(in billions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Cash & Equivalents0.100.240.270.230.180.170.100.100.080.240.180.250.110.150.130.200.05
Short-term Investments0.070.030.070.090.080.240.220.390.290.200.100.130.130.190.260.26--
Total Current Assets0.190.300.390.370.320.470.380.540.440.510.350.440.310.430.540.590.08
Property, Plant & Equipment0.010.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.02
Goodwill0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Intangible Assets0.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.02
Total Non-current Assets*0.070.070.080.080.090.080.080.080.070.070.070.070.070.070.070.070.06
Total Assets0.260.370.470.450.410.550.460.620.510.580.420.510.380.510.620.660.14
Accounts Payable0.010.010.010.010.020.020.020.020.020.020.040.020.010.010.010.010.00
Total Current Liabilities0.060.060.050.120.110.120.160.150.150.160.090.060.060.090.110.090.03
Total Non-current Liabilities*0.300.300.280.280.310.290.040.040.040.040.030.030.030.030.030.030.01
Total Liabilities0.360.360.340.400.430.420.200.190.190.200.120.090.090.120.150.120.04
Retained Earnings(2.48)(2.35)(2.22)(2.08)(1.94)(1.77)(1.57)(1.35)(1.16)(1.00)(0.68)(0.50)(0.35)(0.25)(0.16)(0.09)--
Total Stockholder Equity(0.10)0.010.130.05(0.02)0.130.260.420.320.380.300.430.290.390.470.540.10
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Research & Development101.85100.81103.83121.95141.17184.37187.58167.47157.61314.82155.97134.8195.5279.4963.46137.0452.85
Selling, General & Admin24.5724.0926.6020.7928.2127.3333.9822.4620.5618.9527.2718.9015.0314.5214.3276.3714.79
Operating Income(126.42)(124.90)(130.43)(142.73)(169.38)(211.70)(221.56)(189.93)(178.17)(333.77)(183.24)(153.71)(110.55)(94.01)(77.78)(213.41)(67.64)
Pretax Income(129.34)(136.92)(130.26)(145.20)(173.22)(197.89)(221.07)(186.79)(160.36)(319.59)(178.93)(145.97)(105.86)(88.17)(69.55)(215.25)(67.64)
Tax Provision(0.06)0.390.270.350.220.260.610.05(0.06)0.180.57(1.21)(3.29)2.180.94(14.14)1.22
Net Income(129.28)(137.31)(130.53)(145.55)(173.44)(198.15)(221.68)(186.84)(160.30)(319.77)(179.50)(144.76)(102.57)(90.35)(70.49)(201.11)(68.85)
Basic EPS(0.86)(0.91)(0.88)(1.11)(1.64)(1.94)(2.17)(1.74)(1.70)(3.64)(2.20)(1.88)(1.50)(1.32)(1.03)(3.37)(1.75)
Diluted EPS(0.86)(0.91)(0.88)(1.11)(1.64)(1.94)(2.17)(1.74)(1.70)(3.64)(2.20)(1.88)(1.50)(1.32)(1.03)(3.37)(1.75)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Operating Cash Flow(106.85)(85.10)(149.92)(130.66)(145.72)(167.94)(165.12)(170.74)(141.28)(167.80)(102.64)(114.88)(94.81)(44.39)(77.64)(75.41)(222.28)
Capital Expenditures0.180.450.000.010.010.230.460.050.612.950.440.471.250.600.740.305.77
Free Cash Flow*(107.03)(85.55)(149.92)(130.67)(145.73)(168.17)(165.58)(170.79)(141.89)(170.75)(103.08)(115.35)(96.06)(44.99)(78.37)(75.71)(228.06)
Investing Cash Flow(35.33)44.8215.21(13.74)164.97(15.55)164.88(87.68)(93.40)(97.93)34.03(3.91)58.5576.25(1.06)(264.02)(40.77)
Financing Cash Flow0.213.80179.02188.800.12249.830.37272.8580.38321.123.42245.24(39.66)(20.34)26.67530.18237.42
← Scroll for more columns →

* Derived from reported values